Document is current
Any future updates will be listed below
-
Authors
Shi, Hongyu
Williams, Marc J. https://orcid.org/0000-0001-5524-4174
Satas, Gryte
Weiner, Adam C. https://orcid.org/0000-0002-5968-3606
McPherson, Andrew https://orcid.org/0000-0002-5654-5101
Shah, Sohrab P. https://orcid.org/0000-0001-6402-523X
-
Funding
Funding for this research was provided by:
Cancer Research UK (C42358/A27460)
U.S. Department of Health & Human Services | National Institutes of Health (RM1-HG011014)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30-CA008748)
Cycle for Survival supporting Memorial Sloan Kettering Cancer Center
- License Information
-
More Information
Article History
Received: 18 January 2023
Accepted: 1 March 2024
First Online: 20 March 2024
Competing interests
: SPS is a consultant to AstraZeneca Inc., outside the scope of this work. SPS received funding from Bristol Meyers Squibb Inc. The remaining authors declare no competing interests.
